Science and Enterprise

Tag: grant

  • Study to Test Increasing Ethnic Genetic Disease Diversity

    5 April 2016. The personal genetics company 23andMe is beginning a study to test techniques for increasing the diversity of disease-causing genetic variations, which now overwhelmingly favor Europeans. The study is funded by a $260,000 Small Business Innovation Research grant from National Institutes of Health. The study aims to provide better tools for genetics researchers…

  • Foundation Supporting ALS Progression Model Study

    31 March 2016. A study to validate computer models that predict progression and survival of patients with ALS is underway by a bioinformatics company and biopharmaceutical developer. The 3-year project is funded by a grant of nearly $500,000 from ALS Association in Washington, D.C. ALS, or amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease,…

  • Breast Cancer Academic Research Program Launched

    23 February 2016. Breast Cancer Research Foundation in New York began a new initiative to attract more academic researchers to take part in clinical trials of cancer therapies. The group is starting its Drug Research Collaborative, with a $15 million contribution from drug maker Pfizer, that is also granting research access to its cancer drug…

  • Bayer Funding Studies of Honey Bee Health, Management

    18 February 2016. Bayer Crop Science is seeking research ideas for improving the health of honey bee colonies in the U.S. Proposals for studies in the $1 million program addressing urgent needs highlighted by Bayer’s Healthy Hives 2020 initiative are due by 1 March 2016. Bees, which play a key role in agriculture, are facing…

  • Gene Editing Enlisted to Fight Citrus Greening

    11 February 2016. Plant scientists at University of California in Riverside plan to use genome editing to develop varieties of citrus fruit resistant to a bacterial disease devastating crops in the U.S. and other parts of the world. The five-year research project led by UC-Riverside plant pathologist Wenbo Ma is funded by a $4 million…

  • Tick Genome Sequenced, Control Strategies ID’ed

    10 February 2016. A research consortium on three continents sequenced the genome of the black-legged tick, the insect responsible for Lyme disease and other conditions. The team of 93 authors from 46 institutions, led by entomologist Catherine Hill at Purdue University, published its findings in yesterday’s (9 February) issue of the journal Nature Communications, with…

  • NSF Grant Funds Biosensing Laser Research

    9 February 2016. An engineering professor at University of Texas in Arlington received a grant from National Science Foundation for research on lasers with fluid samples to detect indicators of disease. Yuze Sun, known as Alice, is the recipient of a $500,000 Faculty Early Career Development award from NSF, expected to run through 2020. Sun’s…

  • Stent Implants Demonstrated to Transmit Brain Activity

    9 February 2016. A team of engineers and medical researchers in Australia show it’s possible to safely implant electrodes in the brain to transmit brain activity with a catheter-delivered stent. A description of the device and delivery process with sheep appears in yesterday’s (8 February) issue of the journal Nature Biotechnology (paid subscription required). The…

  • $100K Challenge Seeks Reinvented Clinical Trials

    28 January 2016. A challenge at Harvard Business School seeks proposals for better ways of conducting clinical trials that bring to market faster new precision diagnostics and therapies. The competition has a total prize purse of $100,000 and an initial deadline of 13 March 2016. Precision medicine is the term given to emerging practices bringing…

  • Business-Academic Coop to Fund Translational Research

    25 January 2016. Three pharmaceutical companies and three universities in the U.K. are forming an independent consortium to support academic research leading to new therapies. The £40 million ($US 57 million) Apollo Therapeutics Fund will be financed by contributions from global pharmaceutical enterprises AstraZeneca, GlaxoSmithKline, and Johnson & Johnson, for work in research labs at…